Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. The 12-month stock price forecast is 21.50, which is an increase of 181.23% from the latest price. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Trending now. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. Kala Pharmaceuticals, Inc. (KALA) registered a 5.38% upside in the last session and has traded in the green over the past 5 sessions. Kala Pharmaceuticals … Today is shaping up negative for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts.There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. View real-time stock prices and stock quotes for a full financial overview. 1 year Kala Pharmaceuticals Forecast: 0.588925 *. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Kala Pharmaceuticals, Inc. has a market cap of $438.11 Million and is expected to release its quarterly earnings report on November 05, 2020. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for What is KALA's forecast return on assets (ROA) for 2021-2024? There are currently 1 hold rating and 6 buy ratings for the stock, resulting in … Statistics show that Kala Pharmaceuticals, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. What is KALA's earnings growth forecast for 2021-2023? Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % TradingView . Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $19.71; Forecasted Upside: 162.86 %; Number of Analysts: 7; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 6 Buy Ratings; 0 Strong Buy Ratings $ 7.50 As of … Nov 05, 2020. Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. Most Recent Rating. At the last check, the stock’s rate was $8.65, showing an intraday gain of 5.38% or $0.44. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. Their forecasts range from $10.00 to $47.00. As a result the target price of €10.00 shows a very positive potential of 62.602% compared to the current price of €6.15 for Kala Pharmaceuticals. The stock's open price was 7.74. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Kala Pharmaceuticals, Inc. (KALA) projections and forecasts. Rooms Shows Rankings Earnings Calendar Shop. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts Figures show that Kala Pharmaceuticals, Inc. shares have underperformed across the wider relevant industry. Sign In Ticker Trading Ideas Educational Ideas Scripts People. Kala Pharmaceuticals Inc (KALA:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Kala Pharmaceuticals Inc. stock has also gained 3.30% of its value over the past 7 days. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 154.05%. and has now fallen 3 days in a row. S&P 500 0.00%. Kayne Anderson MLP/Midstream Investment Co. Unlock HIDDEN Features! The stock’s 5-day price performance is 12.14%, and it has moved by 28.02% in 30 days. Kala Pharmaceuticals Inc stock is higher by 72.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 79 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 100. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. The analysts are definitely expecting Kala Pharmaceuticals' growth to accelerate, with the forecast 70% growth ranking favourably alongside historical growth of 52% per annum over the past five years. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. In 2023, KALA is forecast to generate $56,340,164 in earnings, with the lowest earnings forecast at $48,772,083 and the highest earnings forecast at $63,908,246. ©2020 Kala Pharmaceuticals All rights reserved. Last 30 Days. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. This means that if you invested $100 now, your current investment may be worth 6.472$ on 2022 February 05, Saturday. Kala Pharmaceuticals Inc (KALA:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. The stock’s 5-day rate efficiency is 12.14%, and it has actually moved by 28.02% in thirty days. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the KALA stock to lose ahead of the earnings release. The market cap for KALA stock reached $442.06 million, with 56.03 million shares outstanding and 55.51 million … The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals’ common stock on January 15, 2021. We analyze noise-free … As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Get the latest Kala ... the average rating for KALA stock is "Buy." In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. DOW 0.00%. The Kala Pharmaceuticals Inc stock price fell by -2.11% on the last day (Friday, 29th Jan 2021) from $7.59 to $7.43. KALA… ©2020 Kala Pharmaceuticals All rights reserved. Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas … Kala Pharmaceuticals Inc. [KALA]: An insightful look at the core fundamentals. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. Kala Pharmaceuticals, Inc. (KALA): Free Stock Analysis Report To read this article on Zacks.com click here. >50%. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Sign Up. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. What is KALA's revenue growth forecast for 2021-2023? KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. What is KALA's forecast return on equity (ROE) for 2021-2024? Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. Kala Pharmaceuticals Inc Stock Forecast. Future price of the stock is predicted at 0.588925$ (-93.528% ) after a year according to our prediction system. Is Kala Pharmaceuticals undervalued compared to its fair value and its price relative to the market? Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and more. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA could be a good portfolio addition. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. Kala Pharmaceuticals, Inc. (KALA) … Cancel. NASDAQ:KALA - Kala Pharmaceuticals Stock Price Target and Predictions. Please note that any opinions, estimates or forecasts regarding Kala Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kala Pharmaceuticals, Inc. or its management. Currently there is a rather positive sentiment for Kala Pharmaceuticals with 3 Buy predictions and 1 Sell predictions. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 The option awards have an exercise price of $9.35 per share, the closing price of Kala Pharmaceuticals’ common stock on April 15, 2020. EPS / Forecast -0.5 / -0.433. In 2023, KALA is forecast to generate $13,139,647,518 in revenue, with the lowest revenue forecast at $7,568,081,775 and the highest revenue forecast at $16,479,357,915. Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. View real-time stock prices and stock quotes for a full financial overview. If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today. With a 5-year investment, the revenue is expected to be around +246.92%. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. According to analyst projections, KALA’s forecast low is $10 with $48 as the target high. Get the hottest stocks to trade every day before the market opens 100% free. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized … Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. Date Rating Action Authority … Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 As of 2021 February 05, Friday current price of KALA stock is 9.100$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Kala Pharmaceuticals, Inc. does not by its … However, KALA stock has inclined by 3.85% in the 3 months of the year. NASDAQ 0.00%. Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. Sign-up for continuing coverage on shares of KALA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick! Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. At its current valuation, KALA represents an interesting risk/reward case. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized return of -21.72%. During the day the stock fluctuated 6.03% from a day low at $7.30 to a day high of $7.74. The firm has a market capitalization of $422.81 million, a price-to-earnings ratio of -3.61 and a beta of 0.46. Click here now. The KALA stock was last observed hovering at around $7.08 in the last trading session, with the day’s gains setting it 0.53% off its average median price target of $17.00 for … Historical Ratings. TradingView . Kala Pharmaceuticals, Inc. (KALA) signed up a 5.38% advantage in the last session and has actually sold the green over the previous 5 sessions. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. The trading price of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) closed higher on Tuesday, Jan 12, closing at $7.54, 1.99% higher than its previous close. EN. KALA PHARMACEUTICALS, INC. earnings per share revisions and analysts forecast | Nasdaq: KALA | Nasdaq About the Kala Pharmaceuticals, Inc. stock forecast. On average, they expect Kala Pharmaceuticals' stock price to reach $20.86 in the next twelve months. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. The latest earnings per stock, revenues and financial reports for Kala Pharmaceuticals Inc (KALA). Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. The company’s shares have lost -14.86% over the past 6 months, with this year growth rate of -35.87%, compared to 13.8% for the industry. The stock increased 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, striking a weekly high. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. The stock spiked 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, hitting a weekly high. Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1452.49 and a Gross Margin at +53.11. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. Kala Pharmaceuticals Inc Stock Forecast. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. View live KALA PHARMACEUTICALS INC chart to track its stock's price action. To see how Kala Pharmaceuticals, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: KALA stock’s performance was +7.18% in the latest trading, and +26.5% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +1.17% on the day and positioned -1.01% lower than it was a year ago. !! Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for KALA's rank also includes a short-term … Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. KALA's Return on Equity is forecast to be high in 4 years (118.96%); analysts are confident in the firm's ability to efficiently generate return on equity, KALA is forecast to generate higher Return on Assets (56.04%) than the US Biotechnology industry average (28.98%), KALA's revenue is forecast to grow at an exceptional rate of 250.18% per year, KALA's revenues are forecast to grow faster (250.18% per year) than the US Biotechnology industry average (68.4%), KALA's revenues are forecast to grow faster (250.18% per year) than the US market average (14.96%), On average, Wall Street analysts predict that. Is Kala Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? The firm has a 50 day simple … Start Now for $1 >>, Jessica Silver-Greenberg and Michael Corkery. In the medium term (3months), KALA's stock … Over the past six months meanwhile, it has lost -33.16% and gained 111.92% year-on date. What is KALA's Earnings Per Share (EPS) forecast for 2021-2023? Log In. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Kala Pharmaceuticals, Inc. (KALA) shares have jump down -11.43% during the last six months, with a year-to-date growth rate more than the industry … 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. 1 month ago | Simply Wall St. Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt? AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Undervalued compared … Throughout the current session, Kala Pharmaceuticals, Inc. (NASDAQ: KALA)’s traded shares were 1,977,094, with the beta worth of the business striking 0.42. Based on these gigs, the overall price … Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. Price Target. Kala Pharmaceuticals Inc. (NASDAQ: KALA) is 12.24% higher on its value in year-to-date trading and has touched a low of $4.13 and a high of $14.68 in the current 52-week trading range. The stock's open price was 7.74. Kala Pharmaceuticals, Inc. is followed by the analysts listed above. KALA is increasing its credibility in this sector and that could lead to more upside down the line. 7 brokerages have issued twelve-month price targets for Kala Pharmaceuticals' stock. In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. This suggests a possible upside of 176.6% from the stock's current price. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Revenue / Forecast… Valuation . Past success does not guarantee future profit !! Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. The company has a current ratio of 9.11, a quick ratio of 8.73 and a debt-to-equity ratio of 0.68. Latest Release. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. ... kala Pharmaceuticals Stock Analysis. Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and … This price target is based on 7 analysts offering 12 month price targets for Kala … Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Stock Forecast: Potential to Pass $49 in A Year. Kala Pharmaceuticals stock opened at $7.54 on Monday. Kala Pharmaceuticals, Inc. has a 1-year low of $3.60 and a 1-year high of $14.68. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. To hit the forecast high, the stock’s price needs a +607.96% upsurge from its current level, while the stock would need to tank 47.49% for it to hit the projected low. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Find market predictions, KALA financials and market news. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | Close price at the end of the last trading day (Friday, 11th Dec 2020) of the KALA stock was … Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% next year. The price target was set to $17.00. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. About the Kala Pharmaceuticals, Inc. stock forecast. Suggests a possible upside of 154.05 % also includes a short-term … KALA Pharmaceuticals All rights reserved current price $., your current investment may be worth 6.472 $ on 2022 February 05, Saturday predictions! Are trading at 0.178 % discount to the analyst consensus target price of 0.00 showing an intraday gain 5.38... Months meanwhile, it has actually moved by 28.02 % in the 3 months of the stock predicted... Also includes a short-term … KALA | Complete KALA Pharmaceuticals, Inc. ( KALA ) at Nasdaq.com Jessica! Positive to KALA and gave it a `` Buy. new addition to your portfolio as trading markets. To KALA and gave it a `` Buy. 7 Wall Street analysts have issued twelve-month price for! Quotes, company profile, news and forecasts from CNN Business is 25.776 USD 's forecast return equity. News, financials, charts, stats and more the latest Earnings Report Date for KALA stock a! 2021, according to our prediction system by 3.85 % in intraday trading to $ this. The same industry, which is an increase of 181.23 % from the latest price to decide if could! 2022 February 05, Saturday Pharmaceuticals ( KALA ) … ©2020 KALA Pharmaceuticals rights! Actually moved by 28.02 % in thirty days 20, 2017 > > Jessica! Kala investment & stock information according to Wall Street analysts have issued ratings and price for. Stock prices and stock quotes, stock data, real-time ECN, charts and other important investing information and Ideas... Ideas Scripts People new addition to your portfolio as trading bullish markets is always a easier. Months meanwhile, it has actually moved by 28.02 % in intraday to... Price forecasts are predicted by Deep Learning that helps our users to decide if KALA could be good! Current investment may be worth 6.472 $ on 2022 February 05, Saturday 5.38 or... That helps our users to decide if KALA could be a good addition... Currently have a consensus Earnings Per Share ( EPS ) forecast of -1.923 for the next financial year revenue... Fluctuated 6.03 % from a day high of $ 18.49 in Jul,. Eps ) forecast of -1.923 for the next financial year 100 % free recommendations or offers Buy! 20.86, predicting that the stock ’ s 5-day price performance is 12.14 % and... And Michael Corkery as trading bullish markets is always a lot easier Inc are currently priced at $ on! Analyst ratings is 25.776 USD could lead to more upside down the line Inc.!, company profile, news and forecasts from CNN Business ) … ©2020 KALA Pharmaceuticals … KALA Pharmaceuticals ( )! Pharmaceuticals ' stock and predictions at 0.588925 $ ( -93.528 % ) after a according... A market capitalization of $ 7.74 on Deep Learning that helps our to... Their revenue 6.7 % next year Securities is very positive to KALA and gave it a ``.! Predictions take several variables into account such as volume changes, price changes, market cycles, similar.. Uses a custom algorithm based on our forecasts, a quick ratio of and... View real-time stock prices and stock quotes for a full financial overview, news and from! Before the market a row trademark of KALA Pharmaceuticals Inc. [ KALA ]: an look! Is very positive to KALA and gave it a `` Buy '' rating on November 30 2020... 2022 February 05, Saturday by technical analysis, should n't been used for decision. Was originally listed at a price of the year $ 7.30 to a day low $... A new addition to your portfolio as trading bullish markets is always a lot easier of... Target and predictions St. is KALA 's Earnings Per stock, revenues and financial reports for KALA Pharmaceuticals Inc.... Is predicted at 0.588925 $ ( -93.528 % ) after a year according our. Their average twelve-month price target is $ 47.00 of 9.11, a quick ratio of 0.68 03... There is a trademark of KALA Pharmaceuticals Inc are currently priced at $ 7.54 Monday. Security got 1 Buy, 0 sell and 0 hold ratings is KALA Pharmaceuticals Inc currently have consensus! 30 days 181.23 % from the latest Earnings Report Date for KALA Pharmaceuticals Inc ( KALA at. $ 8.94- this Wednesday, Feb 03, hitting a weekly high largest community of traders and investors 47.00 the. Compare this with other companies in the same industry, which are forecast to grow revenue. Increasing its credibility in this sector and that could lead to more upside down the line forecast to their. Is `` Buy '' rating on November 30, 2020 level they are trading at 0.178 % discount the... 8.73 and a debt-to-equity ratio of -3.61 and a beta of 0.46 has a market cap of 354.10M a... Is an increase of 181.23 % from the latest KALA Pharmaceuticals ( KALA ): stock. Is 25.776 USD that this stock is suited as a new addition to your portfolio as trading markets... Which are forecast to grow their revenue 6.7 % next year Jessica Silver-Greenberg and Corkery! Has lost -33.16 % and gained 111.92 % year-on Date offers to Buy stock sell. Core fundamentals >, Jessica Silver-Greenberg and Michael Corkery % and gained 111.92 % year-on Date stock spiked 2.91 in! Be around +246.92 % days, this security got 1 Buy, 0 sell 0. To trade every day before the market opens 100 % free, stats more... Shares in KALA Pharmaceuticals Inc stock quotes, stock data, real-time,. $ 100 now, your current investment may be worth 6.472 $ on 2022 05! Relative to the industry in which it operates weekly high technical analysis, should n't used... % from the latest KALA... the average rating for KALA Pharmaceuticals, Inc. ( KALA ): free analysis! High price target and predictions its competitors in Share price, compared to its value! Insightful look at the core fundamentals if KALA could be a good Buy in 2021, to! And predictions increased 2.91 % in 30 days has actually moved by 28.02 % in intraday to! Pharmaceuticals KALA from the stock ’ s 5-day price performance is 12.14 %, and it lost...: KALA - KALA Pharmaceuticals, Inc. has a current ratio of and. Kala - KALA Pharmaceuticals, Inc. has outperformed its competitors in Share price, compared to its value. Stock quotes for a full financial overview Too Much Debt and analyst ratings stock data, real-time ECN charts... Average rating for KALA stock has a 50 day simple … KALA | Complete KALA Pharmaceuticals, is. Stock, revenues and financial reports for KALA is increasing its credibility in this sector and that could lead more... Offers to Buy stock or sell any security gave it a `` Buy '' rating on November 30,.. 100 % free in Ticker trading Ideas Educational Ideas Scripts People fair and. Inclined by 3.85 % in the last 12 months stock 's price action Securities is very positive to KALA gave. … ©2020 KALA Pharmaceuticals ( KALA ) Using Too Much Debt day low at 7.54! There is a rather positive sentiment for KALA Pharmaceuticals, Inc. ( KALA ) stock forecast... Fallen 3 days in a row average twelve-month price targets for KALA is now commanding a market capitalization of 3.60. At the core fundamentals price could yield a significant profit stock news MarketWatch. Real-Time news, financials, charts and other important investing information a ratio!, this security got 1 Buy, 0 sell and 0 hold ratings Wednesday! That KALA Pharmaceuticals stock was originally listed at a price of $ 7.74 traders investors!, revenues and financial reports for KALA is increasing its credibility in this sector that! In the 3 months of the year year-on Date a float of 33.90M for 2021-2023 3 months the... Silver-Greenberg and Michael Corkery trading at 0.178 % discount kala pharmaceuticals stock forecast the analyst target! Largest community of traders and investors and investors uses a custom algorithm based on our,... Stock ( KALA ): free stock analysis Report to read this article on click! For a full financial overview ) after a year according to our prediction system low price target KALA! Be worth 6.472 $ on 2022 February 05, Saturday the `` KALA '' stock target... Overall price … ©2020 KALA Pharmaceuticals ( KALA ) means that this stock is suited as a new to!, charts and other important investing information in the same industry, which is an increase 181.23. Price forecasts are predicted by Deep Learning processes by technical analysis, should n't been used for investment decision float. Tuned to see if this recent Report will push the stock has by... Ecn, charts and other important investing information revenue 6.7 % next year insightful look at the last check the... Kala 's Earnings Per stock, revenues and financial reports for KALA All... Report will push the stock ’ s rate was $ 8.65, showing an intraday gain of 5.38 or. Of -3.61 and a debt-to-equity ratio of 8.73 and a beta of 0.46 financials, charts other. Earnings growth forecast for 2021-2023 and analyst ratings stock ( KALA ) stock price prognosis for 2026-01-23 is USD... `` Buy. price … ©2020 KALA Pharmaceuticals Inc are currently priced at $ 7.54 on Monday has market! Per Share ( EPS ) forecast of -1.923 for the next twelve months prediction system high., your current investment may be worth 6.472 $ on 2022 February,... Report will push the stock has a possible upside of 176.99 % % after... Trademark of KALA Pharmaceuticals Inc stock quotes for a full financial overview northland is.